Literature DB >> 3401480

Phospholipid asymmetry in cardiac sarcolemma. Analysis of intact cells and 'gas-dissected' membranes.

J A Post1, G A Langer, J A Op den Kamp, A J Verkleij.   

Abstract

The investigation focuses on the phospholipid composition of the sarcolemma of cultured neonatal rat heart cells and on the distribution of the phospholipid classes between the two monolayers of the sarcolemma. The plasma membranes are isolated by 'gas-dissection' technique and 38% of total cellular phospholipid is present in the sarcolemma with the composition: phosphatidylethanolamine (PE) 24.9%, phosphatidylcholine (PC) 52.0%, phosphatidylserine/phosphatidylinositol (PS/PI) 7.2%, sphingomyelin 13.5%. The cholesterol/phospholipid ratio of the sarcolemma is 0.5. The distribution of the phospholipids between inner and outer monolayer is defined with the use of two phospholipases A2, sphingomyelinase C or trinitrobenzene sulfonic acid as lipid membrane probes in whole cells. The probes have access to the entire sarcolemmal surface and do not produce detectable cell lysis. The phospholipid classes are asymmetrically distributed: (1) the negatively charged phospholipids, PS/PI are located exclusively in the inner or cytoplasmic leaflet; (2) 75% of PE is in the inner leaflet; (3) 93% of sphingomyelin is in the outer leaflet; (4) 43% of PC is in the outer leaflet. The predominance of PS/PI and PE at the cytoplasmic sarcolemmal surface is discussed with respect to phospholipid-ionic binding relations between phospholipids and exchange and transport of ions, and the response of the cardiac cell on ischemia-reperfusion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3401480     DOI: 10.1016/0005-2736(88)90557-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  27 in total

1.  Subcellular Ca2+ distribution with varying Ca2+ load in neonatal cardiac cell culture.

Authors:  L L Winka; S Y Wang; G A Langer
Journal:  Biophys J       Date:  1999-05       Impact factor: 4.033

Review 2.  Sarcolemmal calcium binding sites in heart: II. Mathematical model for diffusion of calcium released from the sarcoplasmic reticulum into the diadic region.

Authors:  A Peskoff; J A Post; G A Langer
Journal:  J Membr Biol       Date:  1992-07       Impact factor: 1.843

3.  Diffusion around a cardiac calcium channel and the role of surface bound calcium.

Authors:  D M Bers; A Peskoff
Journal:  Biophys J       Date:  1991-03       Impact factor: 4.033

4.  Understanding the in vivo uptake kinetics of a phosphatidylethanolamine-binding agent (99m)Tc-Duramycin.

Authors:  Said Audi; Zhixin Li; Joseph Capacete; Yu Liu; Wei Fang; Laura G Shu; Ming Zhao
Journal:  Nucl Med Biol       Date:  2012-04-23       Impact factor: 2.408

5.  Inner sarcolemmal leaflet Ca(2+) binding: its role in cardiac Na/Ca exchange.

Authors:  S Y Wang; A Peskoff; G A Langer
Journal:  Biophys J       Date:  1996-05       Impact factor: 4.033

Review 6.  Myocardial fatty acid homeostasis.

Authors:  G J van der Vusse; J F Glatz; H C Stam
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

7.  Polyphosphoinositide inclusion in artificial lipid bilayer vesicles promotes divalent cation-dependent membrane fusion.

Authors:  S A Summers; B A Guebert; M F Shanahan
Journal:  Biophys J       Date:  1996-12       Impact factor: 4.033

8.  Phosphoinositide kinases in rat heart sarcolemma: biochemical properties and regulation by calcium.

Authors:  N Mesaeli; J M Lamers; V Panagia
Journal:  Mol Cell Biochem       Date:  1992-11-18       Impact factor: 3.396

9.  Participation of calcium ions in the molecular mechanism of cardioprotective action of exogenous phosphocreatine.

Authors:  E A Konorev; N V Medvedeva; I V Jaliashvili; V L Lakomkin; V A Saks
Journal:  Basic Res Cardiol       Date:  1991 Jul-Aug       Impact factor: 17.165

10.  Sarcolemmal calcium binding sites in heart: I. Molecular origin in "gas-dissected" sarcolemma.

Authors:  J A Post; G A Langer
Journal:  J Membr Biol       Date:  1992-07       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.